A new imaging based rapid in vivo toxicological screening method
Award amount
$217,130Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Theramix LLC
- Proposal award date
- 2017-08-01
- Contract end date
- 2019-01-31
- UEI
- NPYUSJHF5KS9
- Solicitation number
- PA16-302
- Topic code
- 113
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Toxicological screening in a single animal format
- Creating a bioluminescent mouse model for fast screening of drugs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides
- Novel sorbents for removal of PFAS from water
- A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort
- Development and Evaluation of Rosette Array Technology for HumanNeurodevelopmental Toxicity Screening
- Wearable Multi-Gas Technologies for Monitoring Personal Air Quality
Research funding history
3 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $693,873. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services